ATMA Was The First Private Sector Service Provider In Canada Conducting Legal Psychedelic-Assisted Therapy For A Palliative Care Patient Under The Approval Of Health Canada's Section 56(1)...
CSE:MCUR
MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients
Company Now Is In Two High Growth Rate Global Markets With iSTRYM In The DTx Market, Projected To Reach $56 Billion By 2025 And The Global Psychedelic Market Projected To Reach Over $7.5 Billion By...
This Under-The Radar Stock Is At The Vanguard Of A Huge Emerging Sector…
MINDCURE (CSE:MCUR | OTC:MCURF) MINDCURE –Leading A Healthcare Revolution With Big Data Tech And Ground-Breaking Research The world is suffering from a mental health crisis. It’s only...
The Solution To Our Modern Mental Health Crisis Could Lie Hidden In The Psychedelics Of The 1960s…
MINDCURE (CSE:MCUR | OTC:MCURF) MINDCURE – Leading The Race For Blockbuster Patents In A Revolutionary New Healthcare Market Soon after they were first used as therapeutics in the...
Mind Cure Health’s IPO follows hot on the heels of Compass Pathways sensational debut!
Mind Cure Health Inc. (CSE:MCUR) is launching today, following a successful and oversubscribed IPO on the Canadian Securities Exchange (CSE) on Thursday. Mind Cure is a mental health and wellness...